Kenvue (KVUE) - Total Stockholders' Equity

Public company logo of Kenvue (KVUE)

Kenvue Inc. (KVUE) relies on a powerful base of consumer brands and strong retail ties, which hinders competitor expansion. This chart shows the market price on GURU.Markets is at 10.57, confirming the asset's status. The company generates revenue from the sale of a wide range of hygiene products and over-the-counter medications. However, litigation regarding legacy drugs and competition from low-cost generics create certain challenges.

KVUE Kenvue Health Book Capitalization (02/21/2024 - 10/28/2026)
Flagship merchandise of Kenvue Inc

Investment reliability in equities is determined by the stability of the issuer's material base. Book capitalization measures the value of net assets by subtracting liabilities from the company's total resources. For Kenvue Inc. (KVUE), this foundation is secured by the global recognition of the Tylenol and Listerine brands. Such high consumer loyalty guarantees capital stability. By analyzing this chart of net assets at book value, an investor assesses the real protection of dividends.

Competitor analysis for Kenvue Inc.

HLN - Book Capitalization|Book Capitalization VRNA|MENS (jyongbio.com) - Total Stockholders' Equity|Company Book Value Ligand LGND|Net Asset Value Amneal Pharmaceuticals, Inc.|Perrigo Company (PRGO) - Book Capitalization|Accounting Value of Company Alvotech Biopharmaceuticals (ALVO)|Book Capitalization LQDA (Liquidia Corporation)|glpg.com - Book Capitalization|Company Book Value ANI Pharmaceuticals, Inc. (ANIP)|MNKD: Accounting Value of Company|AMPH (Amphastar) - Company Book Value|Pacira Corp (PCRX) - Company Net Assets|SPRY (ARS Pharmaceuticals) - Book Capitalization|Book Capitalization theravance.com (TBPH)|Aquestive Therapeutics, Inc. (AQST) - Company Net Assets|Accounting Value of Company SCPH (scpharmaceuticals.com)|TECX: Company Book Value|TNXP - Total Stockholders' Equity|Company Net Assets SXT China SXTC|EPRX - Total Net Assets|Book Capitalization BioHarvest Sciences Inc. BHST|Invizyne Technologies (EXOZ) - Accounting Value of Company|Book Capitalization ORMP (Oramed)|Total Stockholders' Equity ENTX|MindWalk Holdings (HYFT) - Company Book Value|Accounting Value of Company ABVC (abvcpharma.com)|Company Book Value CPIX (Cumberland Pharmaceuticals Inc.)|Book Capitalization Quantum BioPharma Ltd. QNTM|FGEN (FibroGen Corp) - Book Capitalization|TELO: Total Stockholders' Equity|Company Book Value ranitherapeutics.com|Accounting Capitalization Synergy CHC|Company Net Assets Rallybio Corp|Company Book Value Lexaria (LEXX)|Company Net Assets PULM|Book Capitalization ftzy.com.cn (PTHL)|APM: Book Capitalization|LYRA - Total Stockholders' Equity|Company Net Assets Impact BioMedical Inc (IBO)|TNFA - Accounting Value of Company|cbdmd.com - Book Capitalization|PRFX (PainReform Corp) - Book Valuation of Business|Company Book Value Altamira Therapeutics Ltd (CYTO)|Accounting Capitalization lipella.com|Book Capitalization OPTN (OptiNose)|Company Net Assets Pieris Pharmaceuticals Inc PIRS|Company Net Assets PROC|Petros Pharma - Book Valuation of Business|Qilian International - Company Book Value|acelyrin.com (SLRN) - Book Capitalization|TFF Pharmaceuticals, Inc. (TFFP) - Company Net Assets